141 related articles for article (PubMed ID: 29691367)
1. Upregulation of SALL4 by EGFR activation regulates the stemness of CD44-positive lung cancer.
Du W; Ni L; Liu B; Wei Y; Lv Y; Qiang S; Dong J; Liu X
Oncogenesis; 2018 Apr; 7(4):36. PubMed ID: 29691367
[TBL] [Abstract][Full Text] [Related]
2. The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma.
Zeng SS; Yamashita T; Kondo M; Nio K; Hayashi T; Hara Y; Nomura Y; Yoshida M; Hayashi T; Oishi N; Ikeda H; Honda M; Kaneko S
J Hepatol; 2014 Jan; 60(1):127-34. PubMed ID: 24012616
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of SALL4 overcomes cisplatin-resistance through AKT/mTOR signaling in lung cancer cells.
Jiang G; Liu CT
Int J Clin Exp Pathol; 2018; 11(2):634-641. PubMed ID: 31938149
[TBL] [Abstract][Full Text] [Related]
4. SALL4 promotes gastric cancer progression through activating CD44 expression.
Yuan X; Zhang X; Zhang W; Liang W; Zhang P; Shi H; Zhang B; Shao M; Yan Y; Qian H; Xu W
Oncogenesis; 2016 Nov; 5(11):e268. PubMed ID: 27819668
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of
Li J; Zhang Y; Tao X; You Q; Tao Z; Zhang Y; He Z; Ou J
Ann Transl Med; 2020 Dec; 8(24):1678. PubMed ID: 33490190
[TBL] [Abstract][Full Text] [Related]
6. The expression of
Jia X; Qian R; Zhang B; Zhao S
J Thorac Dis; 2016 Oct; 8(10):2682-2688. PubMed ID: 27867542
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/β-catenin pathway in esophageal squamous cell carcinoma.
He J; Zhou M; Chen X; Yue D; Yang L; Qin G; Zhang Z; Gao Q; Wang D; Zhang C; Huang L; Wang L; Zhang B; Yu J; Zhang Y
J Exp Clin Cancer Res; 2016 Jun; 35(1):98. PubMed ID: 27329034
[TBL] [Abstract][Full Text] [Related]
8. The Sal-like 4 - integrin α6β1 network promotes cell migration for metastasis via activation of focal adhesion dynamics in basal-like breast cancer cells.
Itou J; Tanaka S; Li W; Iida A; Sehara-Fujisawa A; Sato F; Toi M
Biochim Biophys Acta Mol Cell Res; 2017 Jan; 1864(1):76-88. PubMed ID: 27773610
[TBL] [Abstract][Full Text] [Related]
9. Expression and clinical significance of SALL4 and LGR5 in patients with lung cancer.
Gautam AK; Wang C; Zeng J; Wang J; Lu J; Wei J; Huang G; Mo B; Luo M; Mo B
Oncol Lett; 2015 Dec; 10(6):3629-3634. PubMed ID: 26788181
[TBL] [Abstract][Full Text] [Related]
10. SALL4 is a marker of poor prognosis in serous ovarian carcinoma promoting invasion and metastasis.
Yang M; Xie X; Ding Y
Oncol Rep; 2016 Mar; 35(3):1796-806. PubMed ID: 26750614
[TBL] [Abstract][Full Text] [Related]
11. CD146-mediated acquisition of stemness phenotype enhances tumour invasion and metastasis after EGFR-TKI resistance in lung cancer.
Zhang F; Wang J; Wang X; Wei N; Liu H; Zhang X
Clin Respir J; 2019 Jan; 13(1):23-33. PubMed ID: 30480362
[TBL] [Abstract][Full Text] [Related]
12. SALL4, a novel marker for human gastric carcinogenesis and metastasis.
Zhang L; Xu Z; Xu X; Zhang B; Wu H; Wang M; Zhang X; Yang T; Cai J; Yan Y; Mao F; Zhu W; Shao Q; Qian H; Xu W
Oncogene; 2014 Nov; 33(48):5491-500. PubMed ID: 24276240
[TBL] [Abstract][Full Text] [Related]
13. Metalloprotease-dependent activation of EGFR modulates CD44
Wise R; Zolkiewska A
Breast Cancer Res Treat; 2017 Nov; 166(2):421-433. PubMed ID: 28791489
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of Sall4 inhibits intrahepatic cholangiocarcinoma cell migration and invasion in ICC-9810 cells.
Zhu L; Huang F; Deng G; Nie W; Huang W; Xu H; Zheng S; Yi Z; Wan T
Onco Targets Ther; 2016; 9():5297-305. PubMed ID: 27601921
[TBL] [Abstract][Full Text] [Related]
15. ALDH1 and SALL4 Expression in Cell Block Samples from Patients with Lung Adenocarcinoma and Malignant Pleural Effusion.
Kanayama T; Taniguchi T; Tomita H; Niwa A; Noguchi K; Matsuo M; Imaizumi Y; Kuroda T; Hatano Y; Okazaki I; Kato T; Hara A
Diagnostics (Basel); 2021 Aug; 11(8):. PubMed ID: 34441397
[TBL] [Abstract][Full Text] [Related]
16. Low-expression of microRNA-107 inhibits cell apoptosis in glioma by upregulation of SALL4.
He J; Zhang W; Zhou Q; Zhao T; Song Y; Chai L; Li Y
Int J Biochem Cell Biol; 2013 Sep; 45(9):1962-73. PubMed ID: 23811124
[TBL] [Abstract][Full Text] [Related]
17. Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways.
Ibrahim SA; Gadalla R; El-Ghonaimy EA; Samir O; Mohamed HT; Hassan H; Greve B; El-Shinawi M; Mohamed MM; Götte M
Mol Cancer; 2017 Mar; 16(1):57. PubMed ID: 28270211
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Cancer Stem Cells in Moderately Differentiated Buccal Mucosal Squamous Cell Carcinoma.
Yu HH; Featherston T; Tan ST; Chibnall AM; Brasch HD; Davis PF; Itinteang T
Front Surg; 2016; 3():46. PubMed ID: 27532037
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory Micro-environment Contributes to Stemness Properties and Metastatic Potential of HCC via the NF-κB/miR-497/SALL4 Axis.
Zhao B; Wang Y; Tan X; Ke K; Zheng X; Wang F; Lan S; Liao N; Cai Z; Shi Y; Zheng Y; Lai Y; Wang L; Li Q; Liu J; Huang A; Liu X
Mol Ther Oncolytics; 2019 Dec; 15():79-90. PubMed ID: 31650028
[TBL] [Abstract][Full Text] [Related]
20. Sal-like 4 (SALL4) suppresses CDH1 expression and maintains cell dispersion in basal-like breast cancer.
Itou J; Matsumoto Y; Yoshikawa K; Toi M
FEBS Lett; 2013 Sep; 587(18):3115-21. PubMed ID: 23954296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
